CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment is a research paper published in eLife (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: R01AI154722
National Institutes of Health
Grant: 5R01AI154722-03
Preserving CTLA-4 immune checkpoint for safer and more effective cancer immunotherapy
FWCI
0.15
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals